MedPath

Neuro- and Biofeedback in Nonsuicidal Self-injury

Not Applicable
Recruiting
Conditions
Emotion Regulation
Nonsuicidal Self Injury
Interventions
Other: Real-time functional magnetic resonance imaging Neurofeedback and Real-time Biofeedback
Other: Sham functional magnetic resonance imaging neurofeedback and sham biofeedback
Registration Number
NCT05656001
Lead Sponsor
Region Östergötland
Brief Summary

Nonsuicidal self-injury (NSSI) is defined as the direct, deliberate destruction of one's own body tissue without suicidal intent, typically including behaviors such as cutting, burning, or hitting oneself. The risk of engaging in NSSI is particularly high during adolescence. NSSI is associated with impairments in emotion regulation and NSSI behavior serves as an attempt to regulate emotion. We propose to examine whether training adolescents with NSSI to self-regulate using emotion regulation skills to down-regulate hemodynamic activity of the salience network, involved in emotional processing. Moreover, we propose to examine whether limbic-prefrontal cortex connectivity can be increased following neurofeedback, thereby helping adolescents find an optimal way to emotionally regulate with the help of neurofeedback, instead of engaging in NSSI to regulate emotions. We also aim to examine effects of real-time biofeedback by investigating if adolescents can regulate their psychophysiological activity during emotional reactivity with biofeedback. Sixty participants with NSSI will be recruited and offered either real-time functional magnetic resonance imaging (rt-fMRI-NF) (n = 30) or real-time biofeedback (n = 30) training. Participants each each condition will then be randomized to either an active or a control condition (n = 15/group). Participants will take part in three runs of feedback training. Changes in emotional reactivity as measured with facial electromyography (EMG) before and after feedback training will be the proximal outcome measure together with changes of the blood oxygenation level dependent (BOLD) response during real-time fMRI-neurofeedback for the neurofeedback training. Proximal outcome measures for the biofeedback will include psychophysiological measures of emotional reactivity (facialEMG). More distal outcome measures for both neuro- and biofeedback will be measures of NSSI: frequency, methods and severity as well as self-report measures of difficulties with regulating emotions, emotional reactivity and psychiatric symptoms.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • ongoing contact at the child- and adolescent psychiatric clinics in both Linköping and Norrköping, Sweden
  • ongoing contact at the primary care facilities in Linköping and Norrköping (Ungdomshälsan, Råd, Stöd & Hälsa)
  • NSSI, independent of psychiatric diagnosis
  • between 15 and 19 years of age
  • having engaged in five or more instances of NSSI during the last six months
  • the patient is cognitively capable to decide for him- or herself
Exclusion Criteria
  • anorexia in starvation with BMI 16 or under
  • substance abuse disorder
  • psychosis
  • needing interpreter
  • intellectual disability
  • and for those who do the neurofeedback, severe claustrophobia, pregnancy and braces

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
real-time functional magnetic resonance imaging neurofeedback and real-time biofeedbackReal-time functional magnetic resonance imaging Neurofeedback and Real-time BiofeedbackThree sessions of real-time functional magnetic resonance imaging neurofeedback (rt-fMRI-NF) or real-time biofeedback training where participants will receive direct visual feedback from the blood oxygenation level dependent (BOLD) imaging signaling from the salience network in rt-fMRI-NF or visual feeback from a physiological signal in the real-time biofeedback (active condition)
Sham feedbackSham functional magnetic resonance imaging neurofeedback and sham biofeedbackThree session where participants will be given a yoked sham feedback as control condition.
Primary Outcome Measures
NameTimeMethod
Emotional reactivityChange from baseline up to 5 weeks

Changes of emotional reactivity is measured with facial electromyography (facialEMG). High zygomatic and corrugator response indicate higher emotional reactivity.

Hemodynamic activityChange from baseline at up to 4 weeks

Changes of the blood oxygenation level dependent (BOLD) response during real-time fMRI-neurofeedback for the neurofeedback training. The aim is to down-regulate the hemodynamic activity in the salience network.

Psychophysiological responseChange from baseline at up to 4 weeks

Changes of psychophysiological response during the real-time biofeedback training. The aim is to decrease the emotional reactivity and psychophysiological response.

Secondary Outcome Measures
NameTimeMethod
Nonsuicidal self-injuryChange from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

Changes of self-reported frequency in nonsuicidal self-injury (NSSI). NSSI frequency is measured using the short 9-item version of the Deliberate Self-Harm Inventory (DSHI). Open ended questions are used for frequency with a range from 0 to several hundreds, depending on participants answers. Higher scores indicate more NSSI frequency and worse outcome.

Emotional reactivityChange from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

Changes of self-reported emotional reactivity. Emotional reactivity is measured with the Emotion Reactivity Scale (ERS). Total scores range from 0 to 84 and a higher score indicates a worse outcome.

Emotional awarenessChange from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

Changes of self-reported emotional awareness. Emotional awareness is measured with Toronto Alexithymia Scale, 20 items (TAS-20). TAS-20 total score ranges from 20 to 100 and higher scores indicate worse outcome.

Difficulties with emotion regulationChange from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

Changes of self-reported difficulties with emotion regulation. Difficulties with emotion regulation is measured using the 16-item version of the Difficulties with Emotion Regulation Scale (DERS-16). Scores range from 16 to 80 where higher scores indicate more difficulties with emotion regulation.

Psychiatric symptomsChange from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

Changes of self-reported psychiatric symptoms. Psychiatric symptomatology is measured with the Trauma Symptom Checklist for Children (TSCC) with subscales: depression, anxiety, dissociation, posttraumatic stress, anger and sexual preoccupation. The total scale ranges from 0 to 162 and higher scores indicate worse outcome.

Self-criticismChange from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

Changes of self-reported levels of self-criticism. Self-criticism is measured with the Self-Rating Scale (SRS). Scores range from 8 to 56, and higher scores indicate higher levels of self-criticism.

Functions of nonsuicidal self-injuryChange from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

Changes of self-reported levels of nonsuicidal self-injury (NSSI) functions. NSSI functions is measured using Clinical Assessment of Nonsuicidal Self-Injury Disorder Index (CANDI). Functions are rated as percentages and scores range from 0 to 100% where higher scores indicate higher usage of a specific NSSI function.

Trial Locations

Locations (1)

Region Östergötland

🇸🇪

Linköping, Sweden

© Copyright 2025. All Rights Reserved by MedPath